期刊文献+

胃癌中CAGE、MAGE-A1和MAGE-A3的去甲基化 被引量:2

DNA hypomethylation of CAGE,MAGE-A1 and MAGE-A3 genes in gastric carcinoma
下载PDF
导出
摘要 目的:探讨肿瘤相关抗原基因(cancer associated antigen gene,CAGE)、黑色素瘤抗原基因-A1(melanoma antigen gene A1,MAGE-A1)、黑色素瘤抗原基因-A3(melanoma antigen gene A3,MAGE-A3)启动子区去甲基化与胃癌临床特点的关系和意义.方法:应用甲基化特异性PCR(methylation specific polymerase chain reaction,MSP)的方法检测30例胃癌和25例正常胃黏膜标本中CAGE、MAGE-A1和MAGE-A3基因启动子区的去甲基化状态,并分析其与胃癌临床病例参数间的关系.结果:胃癌组CAGE、MAGE-A1和MAGE-A3基因启动子去甲基化阳性率(80.0%、60.0%、46.7%)均明显高于正常胃黏膜组(4.0%、0.0%、8.0%,P<0.05).胃癌组中,CAGE基因启动子区去甲基化与淋巴转移和临床分期有关(P=0.016;P=0.026);MAGE-A1基因启动子区去甲基化与组织分化程度和临床分期有关(P=0.042;P=0.002);MAGE-A3基因启动子区去甲基化与淋巴转移和组织分化程度有关(P=0.034;P=0.026).结论:CAGE、MAGE-A1和MAGE-A3基因启动子区去甲基化的检测可能有助于判断胃癌的组织分化程度、淋巴结转移和临床分期,有可能成为胃癌治疗及判断预后的分子标志物. AIM:To investigate the relationship between the hypomethylation of cancer associated antigen gene(CAGE),melanoma antigen gene A1(MAGE-A1) and melanoma antigen gene A3(MAGE-A3) promoters and clinicopathological features of gastric carcinoma.METHODS:The methylation status of CAGE,MAGE-A1 and MAGE-A3 promoter CpG islands was detected by MSP in 30 gastric carcinoma samples and 25 normal controls.The relationship between hypomethylation of CAGE,MAGE-A1 and MAGE-A3 promoters and clinicopathological features of gastric carcinoma was analyzed.RESULTS:The rates of hypomethylation of CAGE,MAGE-A1 and MAGE-3 promoters in gastric carcinoma were signif icantly higher than those in normal controls(80.0% vs 4.0%,60.0% vs 0.0%,46.7% vs 8.0%,all P 0.05).Hypomethylation of CAGE promoter was signif icantly correlated with lymphatic metastasis and TNM stage(P = 0.016,0.026),hypomethylation of MAGE-A1 promoter was signif icantly correlated with tumor differentiation and TNM stage(P = 0.042,0.002),and hypomethylation of MAGE-A3 promoter was signif icantly correlated with tumor differentiation and lymphatic metastasis(P = 0.034,0.026).CONCLUSION:The hypomethylation of CAGE,MAGE-A1 and MAGE-A3 promoter CpG islands may be used as a biomarker to estimate the differentiation,lymphatic metastasis and TNM stage of gastric carcinoma.
出处 《世界华人消化杂志》 CAS 北大核心 2013年第20期1987-1991,共5页 World Chinese Journal of Digestology
关键词 肿瘤相关抗原基因 黑色素瘤抗原基因-A1 黑色素瘤抗原基因-A3 DNA低甲基化 胃癌 Cancer associated antigen gene Melanoma antigen gene A1 Melanoma antigen gene A3 DNA hypomethylation Gastric carcinoma
  • 相关文献

参考文献2

二级参考文献15

  • 1Mou DC, Cai SL, Peng JR, et al. Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells. Br J Cancer, 2002,86 ( 1 ) : 110-116.
  • 2Oberg AN, Lindmark GE, Israelsson AC, et al. Detection of occult tumor ceils in Lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR for CEA and CK20 mRNAs. Int J Cancer, 2004,111(1):101-110.
  • 3De Smet C, Loriot A, Boon T. Promoter-dependent mechanism leading to selective hypomethylation within the 5' region of gene MAGE-A1 in tumor cells. Mol Cell Biol, 2004,24(11): 4781-4790.
  • 4Koga T, Tokunaga E, Sumiyoshi Y, et al. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR. Hepatogastroenterology, 2005,55 (84) : 1131-1135.
  • 5Ishigami S, Sakamoto A, Uenosono Y, et al. Carcinoembryonic antigen messenger RNA expression in blood can predict relapse in gastric cancer. J Surg Res, 2008,148(2):205-209.
  • 6朱正纲.应进一步提高胃癌综合治疗的疗效[J].中华胃肠外科杂志,2007,10(5):403-406. 被引量:13
  • 7Ries J,Schultze-Mosgau S,Neukam F,et al.Investigation of the expression of melanoma antigen-encoding genes (MAGE-A1 to -A6) in oral squamous cell carcinomas to determine potential targets for genebased cancer immunotherapy[J].Int J Oncol,2005,26 (3):817-824.
  • 8Mahdian R,Kokhaei P,Najar H M,et al.Dendritic cells,pulsed with lysate of allogeneic tumor cells,are capable of stimulating MHC-restricted antigen-specific antitumor T cells[J].Med Oncol,2006,23 (2):273 -282.
  • 9Hersey P,Menzies S W,Coventry B,et al.PhaseQ Ⅰ / Ⅱ study of immunotherapy with T-cell peptide epitopes in patients Ⅳ melanoma[J].Cancer Immunol Immunother,2005,54(3):208-218.
  • 10Gospodarowicz MK,Miller D,Groome PA,et al.The p rocess for continuous imp rovement of the TNM classification[J].Cancer,2004,100(1):1-5.

共引文献5

同被引文献41

  • 1高飞,由田,吕晶玉,王运杰.CAGE基因在颅脑肿瘤中的表达及其机制[J].癌变.畸变.突变,2007,19(3):239-241. 被引量:1
  • 2Bomsoo Cho, Yoon Lim, Dae-yeon Lee, et al. Identification and characterization of a novel cancer/ testis antigen gene CAGE [J]. BBRC, 2002, 292(3): 715-726.
  • 3Chen YT, Panarelli NC, Piotti KC, et al. Cancer-testis antigen expression in digestive tract carcinomas: frequent expression in esophageal squamous cell carcinoma and its precursor lesions [J]. Cancer Immunol Res, 2014, 2(5): 480-486.
  • 4He L, Ji JN, Liu SQ, et al. Expression of cancer-testis antigen in multiple myeloma [J]. J Huazhong Univ Sci Technolog Med Sci, 2014, 34(2): 181-185.
  • 5Zhang Y, Bao L, Lu J, et al. The clinical value of the quantitative detection of four cancer-testis antigen genes in multiple myeloma[J]. Mol Cancer, 2014, 13:25.
  • 6Luo B, Yun X, Fan R, et al. Cancer testis antigen OY-TES-1expression and serum immunogenicity in colorectal cancer: its relationship to elinicopathological parameters [J]. Int J Clin Exp Pathol, 2013, 6(12): 2835-2845.
  • 7Kim JJ, Rajagopalan K, Hussain B, et al. CETN1 is a cancer testis antigen with expression in prostate and pancreatic cancers [J]. Biomark Res, 2013, 1(1): 22.
  • 8Cheema Z, Hari-Gupta Y, Kita GX, et al. Expression of the cancer-testis antigen BORIS correlates with prostate cancer [J]. Prostate, 2014, 74(2): 164-176.
  • 9Saini S, Jagadish N, Gupta A, et al. A novel cancer testis antigen, A-kinase anchor protein 4 (AKAP4) is a potential biomarker for breast cancer[J]. PLoS One, 2013, 8(2): e57095.
  • 10Mengus C, Schultz-Thater E, Coulot J, et al.MAGE-A10 cancer/testis antigen is highly expressed in high-grade non-muscle-invasive bladder carcinomas[J]. Int J Cancer, 2013, 132(10): 2459-2463.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部